-
Favipiravir CAS 259793-96-9Favipiravir CAS 259793-96-9, is a broad-spectrum antiviral agent that selectively inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. It is a pyrazinecarboxamide derivative with a...read more
-
Bilastine CAS 202189-78-4Bilastine CAS 202189-78-4, is a second-generation, non-sedating antihistamine belonging to the piperidine derivative class. It is a selective peripheral H₁receptor antagonist used for the...read more
-
Carbocisteine Lysine Salt CAS 49673-81-6Carbocisteine Lysine Salt CAS 49673-81-6, is a salt form of the mucoactive agent carbocisteine (S-carboxymethylcysteine), combined with the amino acid L-lysine to form S-CMC-Lys. It is a blocked...read more
-
Safinamide Mesylate CAS 202825-46-5Safinamide Mesylate CAS 202825-46-5, is a monoamine oxidase type B (MAO-B) inhibitor used for treatment of Parkinson's disease.read more
Indications: idiopathic Parkinson's disease (PD) as add-on... -
Saxagliptin Hcl CAS 361442-04-8Saxagliptin Hydrochloride (Saxagliptin HCl) CAS 361442-04-8, is a dipeptidyl peptidase-4 (DPP-4) inhibitor used for improvement of glycemic control in patients with diabetes...read more
-
Daridorexant Hcl CAS 1792993-84-0Daridorexant Hcl CAS 1792993-84-0, is a new type of oral dual orexin receptor antagonist (DORA) that helps patients fall asleep and maintain sleep by blocking the binding of the wake-promoting...read more
-
Delgocitinib CAS 1263774-59-9Delgocitinib CAS 1263774-59-9, is a topical Janus kinase (JAK) inhibitor. As the world's first approved topical JAK inhibitor for the treatment of skin diseases, it provides a new treatment option...read more
-
Lemborexant CAS 1369764-02-2Lemborexant CAS 1369764-02-2, is a Sleep Initiation and Maintenance Disorders drug used for treatment of adult insomnia characterized by difficulty falling asleep and/or maintaining sleep.read more
-
Viloxazine Hci CAS 35604-67-2Viloxazine Hcl CAS 35604-67-2, is a selective norepinephrine reuptake inhibitor (NRI), also exhibits activity as a 5-HT2C receptor agonist and a 5-HT2B receptor antagonist, treatment of Attention...read more
Feb 07, 2022 · Favipiravir is an antiviral medicine that is used to treat viral infections. Currently it is used in the treatment of Coronavirus disease (COVID-19). Learn about its uses, dosage, side...
Mar 10, 2021 · A favipiravir (a remdesivirhez hasonlóan) a vírus RNS-örökítőanyagának a sokszorozását, magyarul a vírus szaporodását gátolja. A szer egy hamis kódot illeszt be a virális RNS-be, ezzel...
Jun 19, 2020 · Favipiravir 200 mg is the first oral antiviral medication under the trade name FabiFlu for the treatment of mild to severe COVID-19 cases, Glenmark Pharmaceutical launch...
Sep 02, 2020 · Favipiravir (T-705) is a synthetic prodrug, first discovered while assessing the antiviral activity of chemical agents active against the influenza virus in the chemical library of...
Abstract. Favipiravir has been developed as an anti-influenza drug and licensed as an anti-influenza drug in Japan. Additionally, favipiravir is being stockpiled for 2 million people as a...
Favipiravir is one such oral drug that was approved for new and reemerging pandemic influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory...
